Clearside Biomedical: Q1 Earnings Insights
Clearside Biomedical (NASDAQ:CLSD) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Clearside Biomedical missed estimated earnings by 62.5%, reporting an EPS of $-0.13 versus an estimate of $-0.08.
Revenue was up $313.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.15 which was followed by a 42.59% increase in the share price the next day.
Here's a look at Clearside Biomedical's past performance:
|Quarter||Q4 2021||Q3 2021||Q2 2021||Q1 2021|
To track all earnings releases for Clearside Biomedical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.